FLNC and Ewing sarcoma: Furthermore, a comparison of proteomic data of doxorubicin-treated fibroblasts and doxorubicin-treated ES cells identified a unique protein signature of 11 markers, among which COL6A2, PSME1 and FLNC demonstrated clinical significance by survival analysis GSE63155 for ES patients.